Indications for Mitral Valve Replacement in Severe Mitral Regurgitation
Mitral valve surgery is mandatory for symptomatic patients with chronic severe primary MR and LVEF >30%, and for asymptomatic patients with LV dysfunction (LVEF 30-60% or LVESD ≥40 mm), with repair strongly preferred over replacement when technically feasible. 1, 2
Primary Mitral Regurgitation
Class I Indications (Must Operate)
Symptomatic severe primary MR with LVEF >30%:
- Symptoms include decreased exercise tolerance, exertional dyspnea, or heart failure 2
- Severe MR defined by: vena contracta ≥0.7 cm, regurgitant volume ≥60 mL, regurgitant fraction ≥50%, or ERO ≥0.40 cm² 2
- Delaying surgery in these patients results in irreversible ventricular damage and worse outcomes 2
Asymptomatic severe primary MR with LV dysfunction:
- LVEF 30-60% and/or LVESD ≥40 mm (or ≥22 mm/m² BSA for small stature patients) 1, 2, 3
- This prevents irreversible ventricular damage and improves long-term survival 2
Concomitant surgery:
Class IIa Indications (Reasonable to Operate)
Asymptomatic severe primary MR with preserved LV function (LVEF >60%, LVESD <40 mm) when:
- Likelihood of successful durable repair >95% with mortality <1% at a Heart Valve Center of Excellence 1, 4
- New-onset atrial fibrillation develops 4, 3
- Resting pulmonary hypertension present (PA systolic pressure >50 mmHg) 4, 3
Moderate primary MR:
Class IIb Indications (May Consider)
- Symptomatic severe primary MR with LVEF ≤30% 1, 4
- Transcatheter mitral valve repair for severely symptomatic patients (NYHA III-IV) with prohibitive surgical risk despite optimal medical therapy 1
Secondary (Functional) Mitral Regurgitation
The approach to secondary MR differs fundamentally from primary MR, with medical optimization required before any surgical consideration. 2, 3
Mandatory Pre-Surgical Steps
Optimize medical therapy first:
- ACE inhibitors/ARBs, beta-blockers, and aldosterone antagonists 2, 3
- Cardiac resynchronization therapy if device indications met 2, 3
- Reassess MR severity after optimization, as it may improve significantly 3
Class I Indications
Concomitant surgery during CABG:
Class IIa Indications
- Severe secondary MR during other cardiac surgery with LVEF >30% 4
Class IIb Indications
Isolated mitral valve surgery:
- Severely symptomatic patients (NYHA III-IV) with persistent symptoms despite optimal medical therapy 2, 3
- This is a weak recommendation as there is no proven survival benefit from isolated valve intervention for secondary MR 2
Repair vs. Replacement Decision
Mitral valve repair is strongly preferred over replacement in all scenarios where durable repair is achievable. 1, 2, 3
Repair Mandatory
Repair Preferred
Echocardiographic Predictors Favoring Repair
- Chordal length >29 mm 5
- Posterior mitral leaflet length >17 mm 5
- Anterior leaflet length >25 mm 5
- Mitral annulus size >35 mm 5
Factors Favoring Replacement
- Anterior mitral annular calcification 5
- Age >63 years 5
- For secondary MR, the choice between repair and replacement remains controversial with no clear survival advantage for either approach 2
Common Pitfalls to Avoid
Do not delay surgery in symptomatic severe primary MR with preserved LVEF waiting for symptoms to worsen or LVEF to decline—this causes irreversible ventricular damage. 2
Do not perform isolated mitral surgery for secondary MR without first optimizing medical therapy including CRT if indicated. 2, 3
Do not apply primary MR surgical indications to secondary MR—the pathophysiology and surgical indications are fundamentally different. 2